Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Dec;70(6):1263–1266. doi: 10.1038/bjc.1994.484

Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.

T E Ind 1, M Granowska 1, K E Britton 1, G Morris 1, D G Lowe 1, C N Hudson 1, J H Shepherd 1
PMCID: PMC2033666  PMID: 7981086

Abstract

Radioimmunoscintigraphy (RIS) can be used in the preoperative localisation of ovarian carcinoma to demonstrate uptake of radiolabelled monoclonal antibodies into neoplastic tissue. The tissue uptake of radiotracer was evaluated at laparotomy in 16 patients with suspected ovarian cancer who had preoperative RIS using technetium-99m-labelled monoclonal antibodies SM3 and H17E2. A gamma detection probe (gamma DP) was used to measure uptake in possible tumour deposits at operation and also the uptake in tissues resected for histology. The percentage uptake of the initial injected dose of radiotracer was also measured in resected tissues. Activity was found to be significantly higher in malignant than in non-neoplastic tissue by all three methods of evaluation. The gamma DP used peroperatively yielded a 82% sensitivity with a 72% specificity for an uptake ratio of 1.5:1. When tissue was examined immediately after resection, for a 100% specificity the sensitivity was 64%. In vitro measurements of monoclonal antibody uptake by tissue similarly gave a 65% sensitivity with a 100% specificity. Peroperative and immediate post-operative measurements of tissue radioactivity can be performed quickly and conveniently, and in some cases may be of benefit in the localisation of tumour at laparotomy and in providing extra information when tissue is examined by frozen section.

Full text

PDF
1263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burchell J., Gendler S., Taylor-Papadimitriou J., Girling A., Lewis A., Millis R., Lamport D. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 1987 Oct 15;47(20):5476–5482. [PubMed] [Google Scholar]
  2. Critchley M., Brownless S., Patten M., McLaughlin P. J., Tromans P. M., McDicken I. W., Johnson P. M. Radionuclide imaging of epithelial ovarian tumours with 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase. Clin Radiol. 1986 Mar;37(2):107–112. doi: 10.1016/s0009-9260(86)80373-7. [DOI] [PubMed] [Google Scholar]
  3. Davies J. O., Davies E. R., Howe K., Jackson P., Pitcher E., Randle B., Sadowski C., Stirrat G. M., Sunderland C. A. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer. J R Soc Med. 1985 Nov;78(11):899–905. doi: 10.1177/014107688507801104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Enough evidence to operate? Lancet. 1991 May 4;337(8749):1066–1067. [PubMed] [Google Scholar]
  5. Epenetos A. A., Snook D., Hooker G., Begent R., Durbin H., Oliver R. T., Bodmer W. F., Lavender J. P. Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in in the detection of neoplasms of testis, ovary, and cervix. Lancet. 1985 Aug 17;2(8451):350–353. doi: 10.1016/s0140-6736(85)92495-x. [DOI] [PubMed] [Google Scholar]
  6. Granowska M., Britton K. E., Mather S. J., Lowe D. G., Ellison D., Bomanji J., Burchell J., Taylor-Papadimitriou J., Hudson C. R., Shepherd J. H. Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer. Eur J Nucl Med. 1993 Jun;20(6):483–489. doi: 10.1007/BF00175160. [DOI] [PubMed] [Google Scholar]
  7. Granowska M., Mather S. J., Jobling T., Naeem M., Burchell J., Taylor-Papadimitriou J., Shepherd J., Britton K. E. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours. Int J Biol Markers. 1990 Apr-Jun;5(2):89–96. doi: 10.1177/172460089000500208. [DOI] [PubMed] [Google Scholar]
  8. Granowska M., Shepherd J., Britton K. E., Ward B., Mather S., Taylor-Papadimitriou J., Epenetos A. A., Carroll M. J., Nimmon C. C., Hawkins L. A. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings. Nucl Med Commun. 1984 Aug;5(8):485–499. [PubMed] [Google Scholar]
  9. Jackson P. C., Pitcher E. M., Davies J. O., Davies E. R., Sadowski C. S., Staddon G. E., Stirrat G. M., Sunderland C. A. Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2). Eur J Nucl Med. 1985;11(1):22–28. doi: 10.1007/BF00440956. [DOI] [PubMed] [Google Scholar]
  10. Jobling T. W., Granowska M., Britton K. E., Lowe D. G., Mather S. J., Burchell J., Naeem M., Shepherd J. H. Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3. Gynecol Oncol. 1990 Sep;38(3):468–472. doi: 10.1016/0090-8258(90)90093-z. [DOI] [PubMed] [Google Scholar]
  11. Kuhn J. A., Corbisiero R. M., Buras R. R., Carroll R. G., Wagman L. D., Wilson L. A., Yamauchi D., Smith M. M., Kondo R., Beatty J. D. Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer. Arch Surg. 1991 Nov;126(11):1398–1403. doi: 10.1001/archsurg.1991.01410350092013. [DOI] [PubMed] [Google Scholar]
  12. Martin D. T., Hinkle G. H., Tuttle S., Olsen J., Nabi H., Houchens D., Thurston M., Martin E. W., Jr Intraoperative radioimmunodetection of colorectal tumor with a hand-held radiation detector. Am J Surg. 1985 Dec;150(6):672–675. doi: 10.1016/0002-9610(85)90405-2. [DOI] [PubMed] [Google Scholar]
  13. Mather S. J., Ellison D. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med. 1990 May;31(5):692–697. [PubMed] [Google Scholar]
  14. Shepherd J. H., Granowska M., Britton K. E., Mather S., Epenetos A. A., Ward B. G., Slevin M. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer. Br J Obstet Gynaecol. 1987 Feb;94(2):160–167. doi: 10.1111/j.1471-0528.1987.tb02344.x. [DOI] [PubMed] [Google Scholar]
  15. Travers P., Bodmer W. Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast-associated determinants. Int J Cancer. 1984 May 15;33(5):633–641. doi: 10.1002/ijc.2910330514. [DOI] [PubMed] [Google Scholar]
  16. Waddington W. A., Davidson B. R., Todd-Pokropek A., Boulos P. B., Short M. D. Evaluation of a technique for the intraoperative detection of a radiolabelled monoclonal antibody against colorectal cancer. Eur J Nucl Med. 1991;18(12):964–972. doi: 10.1007/BF00180417. [DOI] [PubMed] [Google Scholar]
  17. van Dam P. A., Lowe D. G., Watson J. V., Jobling T. W., Chard T., Shepherd J. H. Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2. Cancer. 1991 Jul 1;68(1):169–177. doi: 10.1002/1097-0142(19910701)68:1<169::aid-cncr2820680130>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES